Are you Dr. Peppercorn?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 72 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
101 Manning Dr
Chapel Hill, NC 27599Phone+1 919-966-4996Fax+1 919-843-5515- Is this information wrong?
Summary
- Dr. Amanda Peppercorn, MD is an infectious disease specialist in Chapel Hill, North Carolina. She is currently licensed to practice medicine in North Carolina and Massachusetts.
Education & Training
Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2002 - 2005- Massachusetts General HospitalResidency, Internal Medicine, 1998 - 2001
Harvard Medical SchoolClass of 1998
Certifications & Licensure
MA State Medical License 2001 - 2025
NC State Medical License 2005 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP) Start of enrollment: 2006 May 01
Publications & Presentations
PubMed
- 2 citationsPopulation Pharmacokinetic/Pharmacodynamic Analysis of Intravenous Zanamivir in Healthy Adults and Hospitalized Adult and Pediatric Subjects With Influenza.Peiying Zuo, Jon Collins, Malek Okour, Aline Barth, Denise Shortino, Phillip J. Yates, Grace Roberts, Helen A. Watson, Amanda Peppercorn, Mohammad Hossain> ;Clinical and Translational Science. 2020 Jan 1
- 10 citationsThe safety, tolerability, and pharmacokinetic profile of GSK2838232, a novel 2nd generation HIV maturation inhibitor, as assessed in healthy subjects.Mark Johnson, Roxanne C. Jewell, Amanda Peppercorn, Elizabeth Gould, Jianfeng Xu, Yu Lou, Matt Davies, Sandra J. Baldwin, Allan R Tenorio, Matthew Burke, Jerry Jeffrey...> ;Pharmacology Research & Perspectives. 2018 Jun 5
- 23 citationsIntravenous Zanamivir in Hospitalized Patients With Influenza.John S. Bradley, Jeffrey L. Blumer, Jose R. Romero, Marian G. Michaels, Flor M. Munoz, David W. Kimberlin, Barbara A. Pahud, Roberta L. DeBiasi, Go Yamamoto, G B Rober...> ;Pediatrics. 2017 Nov 1
- Join now to see all
Press Mentions
'Like Somebody Gave Me a Happy Pill:' Monoclonal Antibodies Are Helping the Americans Most at Risk for COVID-19April 17th, 2021- To Get Ahead of Variants, Covid-19 Drug Makers Use Evolutionary Biology as a GuideFebruary 20th, 2021
